Attaboy Lab Continues Rapid Subscription Growth, Adding $800,000 in Monthly ARR as Malar Expands Investment, CEO Joins Board

Attaboy Lab Continues Rapid Subscription Growth, Adding Approximately $800,000 in ARR Per Month as Malar Group Expands Investment and CEO Sayan Navaratnam Joins Board 

Sayan Navaratnam takes a board seat as the wellness brand enters its next phase of growth, with international expansion and new product launches ahead.

TORONTO--(BUSINESS WIRE)--Attaboy Labs, Inc., the wellness company behind the clinically-dosed daily supplement Every Damn Day, has added approximately $800,000 in new annual recurring revenue each month in recent months, sustaining a rate of growth rarely achieved by consumer brands just 13 months after launch. This exceptional performance has prompted Malar Group to expand its investment in the company, with CEO Sayan Navaratnam joining Attaboy Labs, Inc. board of directors.

Since launching on June 20, 2025, Attaboy’s growth has been driven through subscription retention not one-time purchase volume – a reflection of the company's core belief that consumers are looking for a simpler, more trusted way to meet their daily wellness needs through clinically dosed, fully transparent products designed to become part of their everyday routine. In a market where customer acquisition is expensive and churn is high, customer retention has become a powerful driver of Attaboy's compounding growth.

Attaboy’s growing profile is also creating opportunities beyond the direct-to-consumer channel. Attaboy supplements were supplied to the Westbrook E1 racing team for the recent Monaco race, with the brand's clinically-dosed formulations available to team personnel.

Malar deepens its position

Malar Group first invested in Attaboy in April 2026, closing the company's Friends & Family round and joining as a strategic partner. It’s expanded investment reflects conviction built over 13 months of demonstrated performance rather than projected potential.

Navaratnam's appointment to the board formalizes Malar Group’s strategic partnership with the company. In addition to expanded capital, the appointment provides Attaboy with access to Malar's network across global consumer and technology brands as it builds toward international scale.

"We backed Attaboy after one round of diligence. We're increasing our position after thirteen months of watching the business perform," said Sayan Navaratnam, Founder and CEO of Malar Group. "Adding $800,000 in ARR a month, consistently, on a subscription product people don't churn out of – that's a rare thing to find at this stage. Taking a board seat is how we signal that we intend to help build this, not just fund it."

"Malar has been nothing short of a fantastic partner as we continue to grow, and has shown that through their increased investment in Attaboy," said Nick Lawhon, Founder and CEO of Attaboy Labs, Inc.

What's next

Attaboy is building toward global expansion, beginning with entry into the Canadian market in the first half of 2027. The company is also expanding its product line beyond the flagship Every Damn Day formula, with Attagirl, a formulation developed for women, planned for launch in Q2 2027.

About Attaboy Labs Inc.

Attaboy Labs is a wellness brand built on clinically-dosed, transparent formulations. Its flagship product, Every Damn Day, is a once-daily supplement designed to support energy, focus, strength, recovery, and hydration without caffeine or proprietary blends. Attaboy's products are third-party tested and made in Utah with globally sourced, high-quality ingredients. Learn more at attaboylabs.com.

About Malar Group

Malar Group is an investment firm founded and led by Sayan Navaratnam. The firm invests in technology-driven companies and high-conviction consumer brands across industries, with an emphasis on long-term strategic partnership, operator access, and global scaling support. Learn more at malargroup.com.